Loading...
Trametinib in the treatment of melanoma
INTRODUCTION: Aberrant Mitogen Activated Protein Kinase (MAPK) pathway signaling is a hallmark of melanoma. Mitogen/Extracellular signal-regulated Kinase (MEK) 1/2 are integral components of MAPK signaling. Several MEK inhibitors have demonstrated activity as single agents and in combination with ot...
Na minha lista:
| Udgivet i: | Expert Opin Biol Ther |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6684215/ https://ncbi.nlm.nih.gov/pubmed/25812921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2015.1026323 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|